Hawkins Inc. research snapshot
HWKN AI stock analysis currently reads Hawkins Inc. as a steady, well-managed water treatment and specialty chemicals company with recurring revenue streams, consistent free cash flow, and a 30-plus year dividend growth record. At the July 13, 2026 data cutoff, HWKN traded near $137.83 with a verified market capitalization near $2.88 billion. The HWKN AI stock forecast stays scenario-based because the stock trades at a premium valuation for its growth rate, and the current technical position is weak after a sharp pullback from the 52-week high near $186.
Current price
$137.83 intraday on July 13, 2026; previous close $141.40
Market cap
$2.88 billion verified market cap
AI score
65 / 100
Rating
Steady water treatment and specialty chemicals business with consistent execution, moderate growth, and a premium valuation that leaves limited room for error
Trend status
Short-term bearish with price well below the 52-week high and RSI in oversold territory, but long-term trend is constructive from higher lows over five years
Data cutoff (updated weekly)
July 13, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Hawkins distributes, blends, and manufactures water treatment chemicals, food/pharmaceutical ingredients, and industrial chemicals. Revenue is recurring from municipal, food, and industrial customers who depend on daily chemical supply. | Medium-high |
| Moat | The moat comes from customer switching costs, qualified supplier relationships, local service capability, and chemical handling expertise. It is moderate because the products are largely commodity chemicals with limited proprietary differentiation. | Medium |
| Management | CEO Patrick Hawkins leads a family-influenced, long-term-oriented organization. Capital allocation has been disciplined with steady dividend growth, share buybacks, and small bolt-on acquisitions like the April 2026 Aqua-Chem purchase. | Medium-high |
| Financial trend | FY2026 revenue (ended March 29, 2026) was approximately $1.08 billion with net income near $81.55 million. Profit margin of 7.52%, ROE of 16.40%, and levered free cash flow of $75.05 million show consistent but not accelerating financial performance. | High |
| Valuation | At $137.83, verified math shows about 35.3x TTM EPS, 5.2x book value, 2.7x sales, 18.3x EV/EBITDA, and a 0.55% dividend yield. The forward PE of 31.65x still prices in steady growth. | High |
| Technical trend | HWKN is in a short-term downtrend, trading well below the $186.15 52-week high. Barchart reported RSI below 30 (oversold territory) and a 40% Sell technical opinion. The 50-day average volume is about 161,000 shares. | Medium |
| Risk level | Risk is moderate-plus for a small cap. Risks include economic sensitivity of chemical demand, commodity price fluctuations, customer concentration, acquisition integration, and limited liquidity from low trading volume. | Medium-high |
| AI confidence | Descriptive confidence is high for reported financial data. Return confidence is lower because the premium valuation and small cap nature amplify uncertainty. | Medium-high data confidence |
| Investment certainty | HWKN looks like a decent business at a price that already reflects steady-state expectations. The oversold technical condition may create trading opportunities, but the investment margin of safety is thin for a small cap chemical distributor. | Medium-low |
HWKN AI stock forecast
The HWKN AI stock forecast is scenario-based, not a fixed price prediction. Using the July 13, 2026 data cutoff, a $137.83 price reference, $3.91 TTM EPS, and a three-year model, audited scenario math produced about $178 in a bullish case, $108 in a base case, and $59 in a bearish case before dividends.
$170 to $185 before dividends
More likely if water infrastructure spending accelerates, the Food and Health Sciences segment gains traction, Aqua-Chem acquisition delivers above-expected returns, margins expand, and the market re-rates HWKN to a higher growth multiple.
$105 to $115 before dividends
More likely if EPS grows at a mid-single-digit pace, the market applies a more reasonable 20-22x PE multiple, free cash flow remains solid, and the stock trades in line with small cap specialty chemical peers.
$55 to $65 before dividends
More likely if an economic downturn reduces chemical demand, margins compress from competition or input cost pressure, the dividend growth story stalls, or the stock is de-rated as investors demand a higher risk premium for small caps.
HWKN AI technical analysis
HWKN AI technical analysis shows a stock in a short-term downtrend as of the July 13, 2026 data cutoff. Yahoo Finance reported a $137.83 intraday price and $141.40 previous close, with a 52-week range of $117.98 to $186.15. Barchart reported RSI below 30 (oversold), a 40% Sell technical opinion, and a 50-day average volume near 161,000 shares. The stock is well below its 50-day and 200-day moving averages after a sharp decline from the June 2026 highs.
| Level | Value | Why it matters |
|---|---|---|
| Current price reference | $137.83 intraday, $141.40 previous close | Yahoo Finance reported this intraday price on July 13, 2026 with a $2.88 billion market cap. |
| Immediate support | $130 to $132 | The recent trading range low near $131.51 (Barchart 1-month low) creates the first support area. A break below this level would test the 52-week low. |
| Key support | $117 to $118 | Yahoo Finance reported the 52-week low of $117.98. This level represents the last line of defense for the longer-term trend. |
| Near resistance | $145 to $150 | The round $150 level and recent price action create an initial resistance band. Volume may increase if HWKN approaches this zone. |
| Upper resistance | $170 to $175 | Barchart reported a 3-month high near $174.12. This zone represents significant overhead supply from recent sellers. |
| 52-week high reference | $186.15 | Yahoo Finance reported the 52-week high reached on October 6, 2025. This is a reference level, not a near-term price target. |
| Momentum | RSI below 30 (oversold) | Barchart reported RSI in oversold territory. Oversold conditions can precede bounces but do not guarantee trend reversal. |
| Volume | 50-day average about 161,000 shares | Yahoo Finance reported average volume of 161,487 shares. Recent volume has been elevated during the sell-off, which is a continuation signal. |
| Invalidation | Close below $118 | A decisive close below the $117.98 52-week low would invalidate any long-side mean-reversion setup and signal a new leg lower. |
HWKN AI trading strategy
The HWKN AI trading strategy below is a planning framework for research and risk control, not personal investment advice. It connects price behavior with water treatment demand trends, chemical margins, acquisition integration, free cash flow, and small cap valuation risk.
With RSI below 30, an oversold bounce is possible. Watch for HWKN to hold the $130 to $132 support area and then reclaim $140 with higher-than-average volume.
Oversold conditions alone are not a buy signal. A failed hold below $130 should be treated as continuation rather than reversion. Volume confirmation is essential.
HWKN is in a confirmed short-term downtrend. A trend-following approach would wait for the stock to establish a higher low above $130 and then reclaim the 50-day moving average before considering a long position.
Do not attempt to catch a falling knife. The trend-following position is invalidated if HWKN breaks below the $117.98 52-week low.
Track Water Treatment segment growth, margin trends, Food and Health Sciences performance, Aqua-Chem acquisition contribution, free cash flow generation, dividend growth, and any changes in analyst coverage or EPS estimates.
Position sizing should reflect the small cap risk premium. The 35x PE offers limited cushion if earnings disappoint or the market re-rates small cap chemical stocks lower.
Investment research summary
Customers pay Hawkins for reliable, safe supply of essential chemicals that keep municipal water systems, food production, pharmaceutical manufacturing, and industrial processes running every day. The core value is dependability, not innovation.
Hawkins benefits from customer switching costs, local service infrastructure, supplier qualification processes, and chemical handling permits. The moat is moderate because the products are largely commodity chemicals and pricing power is limited by competition and customer sophistication.
The thesis fails if economic weakness reduces chemical demand, water treatment budgets are cut, Food and Health Sciences growth disappoints, the Aqua-Chem acquisition does not integrate well, or the stock loses its premium valuation as interest rates or risk appetite change.
Patrick Hawkins, CEO since 2015, represents a family-influenced leadership culture. Capital allocation has been consistent: dividends raised for over 30 consecutive years, opportunistic buybacks, and disciplined small acquisitions. The key risk is that small cap management teams can make transformational mistakes.
Water infrastructure spending and food safety regulation provide durable demand. Chemical distribution is a mature, slow-growth industry where consolidation and geographic expansion are the primary growth paths. Hawkins competes effectively as a regional player in the US.
At $137.83, HWKN trades at about 35x trailing EPS with a verified market cap of $2.88 billion. This premium multiple for a mid-single-digit grower in a commodity-adjacent industry leaves a thin margin of safety. The three-year scenario model suggests a base case near $108.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| Current price reference | $137.83 intraday on July 13, 2026; $141.40 previous close | Yahoo Finance HWKN summary page | July 13, 2026 |
| Market capitalization | $2.88 billion (intraday), verified against 20.906 million shares | Yahoo Finance and Barchart HWKN key statistics | July 13, 2026 |
| Shares outstanding | 20.906 million | Barchart HWKN fundamentals | July 13, 2026 |
| TTM revenue (FY2026) | Approximately $1.08 billion | Yahoo Finance HWKN statistics | July 13, 2026 |
| TTM net income (FY2026) | Approximately $81.55 million | Yahoo Finance HWKN statistics | July 13, 2026 |
| EPS (TTM) | $3.91 | Yahoo Finance HWKN statistics | July 13, 2026 |
| Segment structure | Water Treatment, Food and Health Sciences, Industrial Solutions | Yahoo Finance HWKN company description | July 13, 2026 |
| Q4 FY2026 results | Revenue $265.91 million, net income $15.48 million, EPS $0.74 | Barchart HWKN most recent earnings | July 13, 2026 |
| FY2026 full year earnings | Reported May 13, 2026 for fiscal year ended March 29, 2026 | GlobeNewswire via Barchart | July 13, 2026 |
| Aqua-Chem acquisition | Completed April 30, 2026, expands Nebraska and Iowa presence | GlobeNewswire via Barchart | July 13, 2026 |
| Cash and debt | $5.61 million cash (MRQ), Debt/Equity 42.30% | Yahoo Finance HWKN statistics | July 13, 2026 |
| Free cash flow | $75.05 million levered free cash flow (TTM) | Yahoo Finance HWKN statistics | July 13, 2026 |
| 52-week range | $117.98 to $186.15 | Yahoo Finance HWKN summary page | July 13, 2026 |
| RSI and technical opinion | RSI below 30 (oversold), 40% Sell Barchart technical opinion | Barchart HWKN technical analysis | July 13, 2026 |
| Average volume | 50-day average approximately 161,000 shares | Yahoo Finance HWKN summary page | July 13, 2026 |
| Analyst ratings | Moderate Buy (5 analysts). Barclays Equal-Weight PT $170. Argus Buy PT range $171 to $180. | Barchart HWKN analyst ratings and Yahoo Finance | July 13, 2026 |
This HWKN AI stock analysis is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell any security. Forecast scenarios are based on public data available at the stated cutoff date, can be wrong, and should be checked against your own research, risk tolerance, and qualified professional advice.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
